Inspire Medical Systems, Inc. | Mid-cap | Healthcare
$83.93
5.40%
| Inspire Medical Stock Comparison:
Inspire Medical vs Abbott LaboratoriesInspire Medical vs Boston ScientificInspire Medical vs PenumbraInspire Medical vs Globus MedicalInspire Medical vs MasimoInspire Medical vs S&P 500 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 201.3M
Gross Profit 170.6M 84.75%
Operating Income -1.5M -0.74%
Net Income 3.0M 1.49%
EPS (Diluted) $0.10

Balance Sheet Metrics

Total Assets 730.8M
Total Liabilities 95.1M
Shareholders Equity 635.7M
Debt to Equity 0.15

Cash Flow Metrics

Operating Cash Flow 8.7M
Free Cash Flow -15.1M

Revenue & Profitability Trend

Inspire Medical Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i802.8M624.8M407.9M233.4M115.4M
Cost of Goods Sold i123.0M96.6M66.1M33.3M17.6M
Gross Profit i679.8M528.2M341.7M200.1M97.8M
Gross Margin % i84.7%84.5%83.8%85.7%84.7%
Operating Expenses
Research & Development i114.1M116.5M68.6M37.4M26.1M
Selling, General & Administrative i529.6M452.0M320.7M202.6M127.9M
Other Operating Expenses i-----
Total Operating Expenses i643.7M568.5M389.3M240.0M154.0M
Operating Income i36.1M-40.3M-47.6M-39.8M-56.2M
Operating Margin % i4.5%-6.4%-11.7%-17.1%-48.7%
Non-Operating Items
Interest Income i23.2M20.6M5.0M125.0K1.1M
Interest Expense i22.0K01.7M2.1M2.1M
Other Non-Operating Income-855.0K-195.0K-49.0K-117.0K145.0K
Pre-tax Income i58.5M-19.9M-44.3M-42.0M-57.1M
Income Tax i4.9M1.2M613.0K72.0K115.0K
Effective Tax Rate % i8.5%0.0%0.0%0.0%0.0%
Net Income i53.5M-21.2M-44.9M-42.0M-57.2M
Net Margin % i6.7%-3.4%-11.0%-18.0%-49.6%
Key Metrics
EBITDA i65.0M-17.1M-40.7M-38.6M-54.1M
EPS (Basic) i$1.80$-0.72$-1.60$-1.54$-2.19
EPS (Diluted) i$1.75$-0.72$-1.60$-1.54$-2.19
Basic Shares Outstanding i2976339529302154280717482726297926073418
Diluted Shares Outstanding i2976339529302154280717482726297926073418

Income Statement Trend

Inspire Medical Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i150.2M185.5M441.6M214.5M190.5M
Short-term Investments i295.4M274.8M9.8M043.8M
Accounts Receivable i93.1M89.9M61.2M34.2M25.1M
Inventory i80.1M33.9M11.9M17.2M8.5M
Other Current Assets12.1M9.6M5.5M2.7M2.0M
Total Current Assets i630.8M593.7M530.0M268.5M269.9M
Non-Current Assets
Property, Plant & Equipment i34.1M9.1M6.5M12.6M8.3M
Goodwill i-----
Intangible Assets i-----
Long-term Investments-----
Other Non-Current Assets11.3M11.3M10.7M204.0K204.0K
Total Non-Current Assets i177.6M83.1M34.8M26.5M11.3M
Total Assets i808.4M676.8M564.9M295.1M281.2M
Liabilities
Current Liabilities
Accounts Payable i38.7M38.8M26.8M11.7M7.2M
Short-term Debt i1.8M-1.3M9.5M-
Current Portion of Long-term Debt-----
Other Current Liabilities-----
Total Current Liabilities i88.5M78.1M61.2M41.3M20.7M
Non-Current Liabilities
Long-term Debt i30.0M24.8M7.5M24.6M30.6M
Deferred Tax Liabilities i-----
Other Non-Current Liabilities148.0K1.3M146.0K134.0K85.0K
Total Non-Current Liabilities i30.2M26.2M7.7M24.7M30.7M
Total Liabilities i118.7M104.3M68.9M66.0M51.4M
Equity
Common Stock i30.0K30.0K29.0K27.0K27.0K
Retained Earnings i-291.9M-345.4M-324.3M-279.4M-237.3M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i689.7M572.5M496.0M229.0M229.7M
Key Metrics
Total Debt i31.8M24.8M8.9M34.1M30.6M
Working Capital i542.3M515.6M468.8M227.2M249.1M

Balance Sheet Composition

Inspire Medical Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i53.5M-21.2M-44.9M-42.0M-57.2M
Depreciation & Amortization i6.6M2.8M1.9M1.2M840.0K
Stock-Based Compensation i116.0M82.5M52.0M26.2M12.8M
Working Capital Changes i-48.2M-42.9M-7.3M-13.2M-12.4M
Operating Cash Flow i129.4M25.0M2.4M-26.5M-54.6M
Investing Activities
Capital Expenditures i-39.1M-23.6M-9.1M-4.7M-2.5M
Acquisitions i-----
Investment Purchases i-418.6M-281.4M-10.5M-10.0M-52.7M
Investment Sales i344.6M10.2M043.8M141.8M
Investing Cash Flow i-113.1M-294.8M-19.6M29.1M86.6M
Financing Activities
Share Repurchases i-75.0M----
Dividends Paid i-----
Debt Issuance i----0
Debt Repayment i00-24.5M0-
Financing Cash Flow i-80.2M-17.2M219.3M0124.7M
Free Cash Flow i91.1M1.0M2.5M-24.8M-55.5M
Net Change in Cash i-63.9M-287.0M202.1M2.6M156.7M

Cash Flow Trend

Inspire Medical Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 45.48
Forward P/E 39.97
Price to Book 3.45
Price to Sales 2.72
PEG Ratio 39.97

Profitability Ratios

Profit Margin 6.17%
Operating Margin -1.53%
Return on Equity 8.07%
Return on Assets 3.38%

Financial Health

Current Ratio 6.14
Debt to Equity 4.88
Beta 1.22

Per Share Data

EPS (TTM) $1.74
Book Value per Share $22.92
Revenue per Share $28.97

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
insp2.3B45.483.458.07%6.17%4.88
Abbott Laboratories 233.7B16.834.6230.93%32.43%26.50
Boston Scientific 152.8B61.396.8111.55%13.55%53.09
Penumbra 9.4B63.627.2212.03%11.54%17.04
Globus Medical 7.9B43.771.848.62%13.58%2.83
Masimo 7.9B129.167.54-22.37%-21.32%61.58

Financial data is updated regularly. All figures are in the company's reporting currency.